36.03
-2.45 (-6.37%)
| Penutupan Terdahulu | 38.48 |
| Buka | 37.99 |
| Jumlah Dagangan | 638,598 |
| Purata Dagangan (3B) | 484,345 |
| Modal Pasaran | 1,791,303,040 |
| Harga / Jualan (P/S) | 3.31 |
| Harga / Buku (P/B) | 3.77 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | -7.95% |
| Margin Operasi (TTM) | -4.82% |
| EPS Cair (TTM) | -0.810 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 13.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 17.03% |
| Nisbah Semasa (MRQ) | 4.11 |
| Aliran Tunai Operasi (OCF TTM) | 22.19 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -10.42 M |
| Pulangan Atas Aset (ROA TTM) | -3.70% |
| Pulangan Atas Ekuiti (ROE TTM) | -8.38% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Menaik | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | AtriCure, Inc. | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 3.5 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 4.0 |
| Purata | 0.80 |
|
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 3.37% |
| % Dimiliki oleh Institusi | 103.60% |
| Julat 52 Minggu | ||
| Median | 64.00 (77.63%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Canaccord Genuity | 30 Oct 2025 | 64.00 (77.63%) | Beli | 34.09 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| NOZNESKY JUSTIN J | - | 36.03 | -5,166 | -186,131 |
| WEHRWEIN SVEN | - | 38.11 | -10,000 | -381,076 |
| Jumlah Keseluruhan Kuantiti Bersih | -15,166 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -567,207 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 37.42 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| NOZNESKY JUSTIN J | Pegawai | 26 Nov 2025 | Jual (-) | 5,166 | 36.03 | 186,131 |
| WEHRWEIN SVEN | Pengarah | 25 Nov 2025 | Jual (-) | 4,967 | 38.48 | 191,130 |
| WEHRWEIN SVEN | Pengarah | 25 Nov 2025 | Pelaksanaan pilihan | 4,967 | - | - |
| WEHRWEIN SVEN | Pengarah | 24 Nov 2025 | Jual (-) | 5,033 | 37.74 | 189,945 |
| WEHRWEIN SVEN | Pengarah | 24 Nov 2025 | Pelaksanaan pilihan | 5,033 | - | - |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 18 Nov 2025 | Pengumuman | AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference |
| 29 Oct 2025 | Pengumuman | AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025 |
| 28 Oct 2025 | Pengumuman | AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial |
| 27 Oct 2025 | Pengumuman | AtriCure to Participate in Upcoming Investor Conferences |
| 08 Oct 2025 | Pengumuman | AtriCure to Announce Third Quarter 2025 Financial Results |
| 09 Sep 2025 | Pengumuman | AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |